ChemicalBook > Product Catalog > Analytical Chemistry > Standard > Pharmaceutical Impurity Reference Standards > (2S,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid
(2S,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid
(2S,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid Basic information
- Product Name:
- (2S,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid
- Synonyms:
-
- (2S,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid
- LCZ 696 Impurity F
- (αS,γR)-γ-[[(1,1-Dimethylethoxy)carbonyl]amino]-α-methyl-[1,1-biphenyl]-4-pentanoic Acid
- Sacubitril Impurity F
- LCZ704
- (2S,4R)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid
- LCZ696696-A-C
- LCZ-696 Impurity 18
- CAS:
- 1012341-54-6
- MF:
- C23H29NO4
- MW:
- 383.48
- Product Categories:
-
- LCZ696
- Mol File:
- 1012341-54-6.mol
More
Less
(2S,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid Chemical Properties
- Boiling point:
- 582.6±50.0 °C(Predicted)
- Density
- 1.115±0.06 g/cm3(Predicted)
- pka
- 4?+-.0.23(Predicted)
More
Less
(2S,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acidSupplier
Zhengzhou Acme Chemical Co., Ltd. Gold
- Tel
- 0371-037163312495,13303845143 13303845143
- 3001379618@qq.com
Adamas Reagent, Ltd.
- Tel
- 400-6009262 16621234537
- chenyj@titansci.com
Jiangsu Vcare PharmaTech Co., Ltd.
- Tel
- 025-58741518; 18013018875
- sales@vcarepharmatech.com
S.Z. PhyStandard Bio-Tech. Co., Ltd.
- Tel
- 0755-4000505016 13380397412
- 3001272453@qq.com
Beijing Comparison Pharmaceutical Technology Co., Ltd
- Tel
- 010-010-52878169 15801002657
- sales@bjcomparison.com
More
Less
(2S,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid(1012341-54-6)Related Product Information
- Sacubitril Impurity 10
- LCZ Impurity
- AHU-377
- Sacubitril Impurity 72
- LCZ696
- LCZ696 interMediate
- (S)-5-[(Biphenyl-4-yl)methyl]-1-(2,2-dimethylpropionyl)pyrrolidin-2-one
- (2R,4S)-4-([1,1'-Biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoic acid
- (2R,4S)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-aMino-2-Methylpentanoate
- ((R)-2-biphenyl-4-yl-1-forMylethyl)carbaMic acid t-butyl ester
- 2-Pyrrolidinone, 5-([1,1'-biphenyl]-4-ylMethyl)-3-Methyl-, (3R,5S)-
- (R,E)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpent-2-enoate
- (2R,4S)-4-([1,1'-Biphenyl]-4-ylmethyl)-4-(4-ethoxy-4-oxobutanamido)-2-methylbutanoic acid
- sacubitril
- (2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpentanoic acid
- AHU-377 (heMicalciuM salt)
- Valsartan
- (2R,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid